trending Market Intelligence /marketintelligence/en/news-insights/trending/IdWDCYtwerAXFMxBxBV6GQ2 content esgSubNav
In This List

PTC Therapeutics chief commercial officer stepping down

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


PTC Therapeutics chief commercial officer stepping down

Mark Rothera agreed to step down as chief commercial officer of PTC Therapeutics Inc., effective Aug. 9.

Rothera entered into a consulting agreement, effective Aug. 10, 2017, with a term continuing through Sept. 30, 2018.